Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
805.50
794.90
687.50
572.60
627.70
622.10
590.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
805.50
794.90
687.50
572.60
627.70
622.10
590.20
Raw Material Cost
17.60
14.00
11.30
9.20
15.50
13.60
15.60
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
49.70
Selling and Distribution Expenses
301.80
291.60
286.30
276.50
287.80
234.30
242.00
Other Expenses
25.82
25.00
24.43
26.32
17.94
18.94
13.50
Total Expenditure (Excl Depreciation)
577.60
555.60
541.90
548.90
482.70
437.30
442.30
Operating Profit (PBDIT) excl Other Income
227.89999999999998
239.3
145.6
23.700000000000003
145
184.8
147.89999999999998
Other Income
25.80
22.20
20.60
21.70
22.50
23.40
22.80
Operating Profit (PBDIT)
261.20
269.20
173.50
53.00
174.60
214.70
178.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
49.70
Exceptional Items
-14.30
30.30
-6.70
-30.70
-4.90
-17.90
-22.40
Gross Profit (PBDT)
787.90
780.90
676.20
563.40
612.20
608.50
574.60
Depreciation
7.50
7.70
7.30
7.60
7.10
6.50
7.30
Profit Before Tax
239.40
291.80
159.50
14.70
162.60
190.30
98.60
Tax
85.70
82.30
52.00
6.80
59.50
60.50
33.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
153.70
209.50
107.50
7.90
103.10
129.80
65.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
153.70
209.50
107.50
7.90
103.10
129.80
65.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
153.70
209.50
107.50
7.90
103.10
129.80
65.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
3,253.10
3,003.60
2,694.30
2,535.70
2,589.70
2,718.90
2,509.20
Earnings per share (EPS)
1.48
2.04
1.06
0.08
1.0
1.24
0.63
Diluted Earnings per share
1.48
2.04
1.06
0.08
1.0
1.24
0.63
Operating Profit Margin (Excl OI)
28.29%
30.1%
21.18%
4.14%
23.1%
29.71%
25.06%
Gross Profit Margin
30.65%
37.68%
24.26%
3.89%
27.04%
31.63%
17.94%
PAT Margin
19.08%
26.36%
15.64%
1.38%
16.43%
20.86%
11.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 28.33% vs 21.84% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 49.08% vs -30.20% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 54.77% vs -2.50% in Dec 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of Neurocrine Biosciences, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
805.50
442.93
362.57
81.86%
Other Operating Income
0.00
0.00
0.00
Total Operating income
805.50
442.93
362.57
81.86%
Raw Material Cost
17.60
408.84
-391.24
-95.70%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
41.00
-41.00
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
20.84
-20.84
-100.00%
Selling and Distribution Expenses
301.80
124.69
177.11
142.04%
Other Expenses
25.82
25.77
0.05
0.19%
Total Expenditure (Excl Depreciation)
577.60
853.02
-275.42
-32.29%
Operating Profit (PBDIT) excl Other Income
227.90
-410.08
637.98
155.57%
Other Income
25.80
22.75
3.05
13.41%
Operating Profit (PBDIT)
261.20
-374.58
635.78
169.73%
Interest
0.00
20.84
-20.84
-100.00%
Exceptional Items
-14.30
0.50
-14.80
-2,960.00%
Gross Profit (PBDT)
787.90
34.10
753.80
2,210.56%
Depreciation
7.50
12.75
-5.25
-41.18%
Profit Before Tax
239.40
-407.68
647.08
158.72%
Tax
85.70
4.55
81.15
1,783.52%
Provisions and contingencies
0
0
0.00
Profit After Tax
153.70
-412.23
565.93
137.29%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
153.70
-412.23
565.93
137.29%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
153.70
-412.23
565.93
137.29%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
3,253.10
1,140.62
2,112.48
185.20%
Earnings per share (EPS)
1.48
-3.93
5.41
137.66%
Diluted Earnings per share
1.48
-3.93
5.41
137.66%
Operating Profit Margin (Excl OI)
28.29%
-92.58%
0.00
120.87%
Gross Profit Margin
30.65%
-89.16%
0.00
119.81%
PAT Margin
19.08%
-93.07%
0.00
112.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 80.55 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 1.33% vs 15.62% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 28.33% vs 21.84% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 15.37 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -26.63% vs 94.88% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 49.08% vs -30.20% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.54 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -4.70% vs 61.54% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 54.77% vs -2.50% in Dec 2024
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.29%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
